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Abstract 
 
Hyperammonemia in the brain leads to poorly understood alterations of nitric oxide (NO) 
synthesis. Arginine, the substrate of nitric oxide synthases, might be recycled from the 
citrulline produced with NO by argininosuccinate synthetase (AS) and argininosuccinate 
lyase (AL). The regulation of AS and AL genes during hyperammonemia is unknown in the 
brain. We used brain cell aggregates cultured from dissociated telencephalic cortex of rat 
embryos to analyse the regulation of AS and AL genes in hyperammonemia. Using RNase 
protection assay and non-radioactive in situ hybridization on aggregate cryosections, we show 
that both AS and AL genes are induced in astrocytes but not in neurons of aggregates exposed 
to 5 mM NH4Cl. Our work suggests that the hyperammonemic brain might increase its 
recycling of citrulline to arginine. 
 
  3 
Inherited disorders of the urea cycle enzymes or liver insufficiency, be it acute or chronic, 
lead to accumulation of ammonia and to deficiency of arginine (except for arginase 
deficiency). In central nervous system (CNS), these conditions lead to reversible and 
irreversible changes, the mechanisms of which are poorly understood. The reversible 
neurological symptoms of hyperammonemia have been partly explained by the cerebral 
detoxication of ammonia through increased formation of glutamate and glutamine [7;14] 
which leads to increased uptake of large neutral amino acids including tryptophan [3]. This 
results in a rise of serotonin concentration and flux in the brain [3;6]. Other alterations, 
affecting glutamatergic, cholinergic and GABAergic neurotransmission, energy metabolism, 
astrocyte morphology as well as glutamate uptake, have also been described in the 
hyperammonemic brain [5;11]. 
 
Arginine synthesis from citrulline is catalyzed by the two cytosolic urea cycle enzymes 
argininosuccinate synthetase (AS) and argininosuccinate lyase (AL). There is no de novo 
synthesis of arginine from ammonia and ornithine in CNS, since the mitochondrial urea cycle 
enzymes carbamoylphosphate synthetase (CPS) and ornithine transcarbamylase (OTC) are 
not expressed in the brain. However, citrulline is produced in CNS by nitric oxide synthases 
(NOS), in the reaction forming nitric oxide (NO) from arginine. Citrulline might be recycled 
to arginine through the CNS expression of AS and AL [2;10]. NOS, AS and AL constitute the 
so-called citrulline-NO cycle. Thus, for fulfilling their needs in arginine, brain cells depend 
on specific transporters to import arginine from the blood [15;17], and on the expression of 
AS and AL. The analysis of the regulation of the citrulline-NO cycle in hyperammonemia, 
and especially of AS and AL genes, is of particular interest, since in experimental 
hyperammonemia NOS activity is increased in different brain regions together with an 
augmentation of the cell uptake of L-arginine [13]. Moreover, OTC deficient spf/Y mice, a 
model of human urea cycle genetic disorders, develop hyperammonemia and present a 
significant decrease in CNS arginine concentration [14]. 
 
In order to study the potential regulation of AS and AL genes in the hyperammonemic CNS, 
we used primary brain cell aggregate cultures issued from the cortex of rat embryos [8], 
exposed to 5 mM ammonium chloride. 
 
Reaggregated brain cell primary cultures were prepared from mechanically dissociated 
telencephalons of 16 day old rat embryos and grown in serum-free chemically defined 
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DMEM containing high glucose (25 mM) [8]. L-arginine concentration was 400 µM. Cultures 
were grown for 21 days and treated from day 5 with 5 mM NH4Cl (or 5 mM NaCl for 
controls). Medium was renewed at days 8 and 11 (5 ml replaced out of 8 ml total). Day 13 
aggregates were washed in PBS and prepared for RNA extraction or embedded for histology. 
 
cDNAs from rat AS [16], AL [1] and ribosomal protein L27 (used for internal control, [9]) 
were obtained by RT-PCR and used for RNase protection assay (RPA) using antisense [α-
32P]UTP-labeled riboprobes [9] (probe length: AS 363 nt, AL 434 nt, L27 270 nt; protected 
fragment length: AS 334 nt, AL 405 nt, L27 220 nt). Specific activities were 109 cpm/µg (1011 
cpm/nmol) for AS and AL and 108 cpm/µg (1010 cpm/nmol) for L27. 8 µg of total RNA were 
hybridized with 1 ng of AS or AL riboprobes and 10 ng of L27 riboprobe. After separation on 
polyacrylamide gel and exposure to x-ray film, autoradiograms were scanned for the measure 
of steady state mRNAs levels. 
 
For histology, aggregates were embedded in tissue freezing medium, frozen in isopentane and 
dry ice, and analyzed by in situ hybridization (ISH) as described [4]. Briefly, cryosections 12 
µm thick were hybridized with digoxigenin-labelled antisense and sense riboprobes for rat AS 
and AL. Hybridization (58°C for 40h in 5xSSC and 50% formamide), washes (30min in 
2xSSC at room temperature, 1h in 2xSSC at 65°C, 1h in 0.1xSSC at 65°C), alkaline-
phosphatase staining (15h) and mounting of the slides were done as described [4]. The 
specificity of hybridization was controlled with the corresponding sense probes for AS and 
AL. Astrocytes and neurons were characterized by immunohistochemistry using monoclonal 
antibodies against glial fibrillary acidic protein (GFAP) and microtubule associated protein 2 
(MAP2) respectively, stained with a secondary anti-mouse IgG bridging antibody together 
with a tertiary alkaline phosphatase / anti-alkaline phosphatase complex. A May-Grünwald 
coloration was performed for overall staining of the aggregates. 
 
Exposing the cultures to NH4Cl resulted in an increased consumption of glucose and 
production of lactate, particularly between days 8 and 11 (Table 1). NH4Cl treated aggregates 
reduced ammonia concentration in the medium, at maximum between days 8 and 11, from 4.5 
to 1.1 mM (Table 1). General effects of NH4Cl treatments were surveyed up to 21 days by 
measuring enzymatic activities of glutamic acid decarboxylase (GAD, GABA-ergic neurons), 
choline acetyltransferase (ChAT, cholinergic neurons) and glutamine synthase (GS, 
astrocytes), as well as protein content [8]. In NH4Cl treated cultures, GAD total activity per 
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culture (n=3) was decreased (800±90 versus 1230±210 pmol/min), whereas ChAT (370±40 
versus 410±80 pmol/min) and GS (230±20 versus 300±40 nmol/min) were moderately 
reduced. The protein content of NH4Cl treated cultures was lower than in controls (1.20±0.20 
versus 1.90±0.30 mg protein/culture). 
 
In both conditions, the AS transcript was barely detectable by RPA and could not be 
quantitated reliably by densitometry (Fig. 1A). The AL mRNA steady state level was 2.8 
times higher in NH4Cl treated aggregates than in controls, relatively to the ribosomal protein 
L27 transcript level (Fig. 1B,C).  
 
Normal day 13 aggregates presented a characteristic distribution of cell types. Neurons of big 
size were organized in a sub-peripheral ring (Fig. 2I, arrowhead) and extended their dendrites 
towards the periphery of the aggregate, as shown by the densely packed fibers stained for 
MAP2 (Fig. 2E, asterisk). Astrocytes were evenly distributed in the aggregate (Fig. 2F,I, 
arrow). Aggregates treated with 5 mM NH4Cl showed a significant reduction in size, which 
fitted the decrease in protein mentioned above. Cells did not seem to have changed in number, 
but were more densely packed within the aggregate. The peripheral dense fiber zone was 
reduced (Fig. 2E,G,I,K, asterisk) and neuron cell bodies were more peripheral (Fig. 2E,G). As 
in control aggregates, astrocytes were distributed evenly, but exhibited a higher GFAP 
immunoreactivity (Fig. 2F,H). 
 
ISH was more sensible than RPA, and allowed us to localize both AS and AL mRNAs. In 
control aggregates, the AS gene was expressed at low levels and not detectable in the 
peripheral dense fiber zone (Fig. 2A,E). It was located both in neurons and astrocytes (Fig. 
2E,F,I). In NH4Cl treated aggregates, the AS gene expression was induced in cells identified 
as astrocytes (Fig. 2C,G,H,K). In the other cells, the low expression of the AS gene was 
maintained at levels found in controls. In control aggregates, the AL mRNA was expressed 
ubiquitously at low levels (Fig. 2B), and was located in both neurons and astrocytes (Fig. 
2E,F,I). The AL transcript was present in the peripheral dense fiber zone, contrary to the AS 
mRNA (Fig. 2A,B,E). In NH4Cl treated aggregates, AL expression was predominantly 
increased in astrocytes, as the AS gene (Fig. 2D,G,H,K). As found for AS, a low expression 
of AL was maintained in the other cells. No signal could be detected on aggregate sections 
hybridized with the respective AS and AL sense control probes (Fig. 2J,L). 
 
This is the first report of AS and AL gene regulation by ammonia in brain cells, showing that 
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both genes are induced in astrocytes under NH4Cl treatment. In the normal rat brain, AS has 
been localized by immunohistochemistry in some but not all neurons, whereas AL was found 
in a specific glial subtype of cerebellum, as well as ubiquitously in neurons [2;10]. During 
hyperammonemia, the NO production was found increased in brain synaptosomes, in parallel 
with an augmentation of their arginine uptake [13]. Our present findings suggests that under 
hyperammonemic conditions, the CNS gene expression of AS and AL is enhanced in 
astrocytes, which could allow a more efficient recycling of citrulline to arginine, the unique 
precursor of NO. 
 
In rat hepatocytes, the AS gene is up-regulated under increasing glutamine  in the medium, 
but not by increased ammonia, in contrast to our present findings in brain [12]. The tissue 
differences of AS and AL gene expression and activities under hyperammonemia might 
provide clues to the understanding of the molecular mechanisms of AS and AL gene 
regulation by ammonia. Among these, membrane transport of citrulline and arginine between 
neurons and astrocytes, regulation of NOS activity and arginine utilization should be 
included. 
 
We thank Drs. M. Mori and H. Henry for a critical reading of the manuscript and fruitful 
discussions. 
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Table 1: Glucose, lactate and ammonia in culture medium. Treatments with 5 mM NaCl 
(control) or 5 mM NH4Cl from day 5 to 13. Medium was renewed at days 8 and 11, by 
replacement of 5 ml on a total of 8 ml. Measures of glucose, lactate and ammonia [mM] were 
done after renewal of medium (days 8 and 11, measure I: initial), and before renewal of 
medium (day 11) or recovery of the aggregates (day 13)(measure F: final). Consumption or 
production between days 8 and 11 as well as between days 11 and 13 are given (F-I, 
[µmol/day/culture]). Mean ± SD, n=3. 
  I F F-I 
Glucose     
days 8-11 NaCl 19.3±0.2 6.4±0.3 -34.5±0.4 
" NH4Cl 18.1±0.1 2.8±0.3 -40.9±0.7 
days 11-13 NaCl 18.0±0.1 3.0±0.5 -60.2±1.6 
" NH4Cl 16.7±0.1 3.9±0.2 -50.9±0.8 
     
Lactate     
days 8-11 NaCl 3.5±0.1 9.2±0.2 15.3±0.7 
" NH4Cl 5.2±0.1 18.9±1.2 36.5±3.3 
days 11-13 NaCl 3.5±0.1 16.5±0.6 52.1±2.2 
" NH4Cl 7.1±0.5 21.7±0.4 58.5±1.2 
     
Ammonia     
days 8-11 NaCl 0.29±0.01 0.13±0.01 -0.42±0.01
" NH4Cl 4.50±0.05 1.10±0.50 -9.10±1.30
days 11-13 NaCl 0.22±0.01 0.17±0.01 -0.21±0.03
" NH4Cl 3.70±0.20 3.00±0.50 -2.70±1.80
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Figure legends: 
 
Fig. 1: Expression of AS, AL and L27 mRNAs in day 13 aggregates. RNase protection 
assay for AS/L27 (A) or AL/L27 (B). Treatment from day 5 to 13 with 5 mM NaCl (-) or 5 
mM NH4Cl (+). Non-digested probes for AS (1), AL (2) and L27 (3). Protected fragments 
indicated by arrows. Gels loaded with 8 µg of total RNA were exposed 14 days (A) and 3 
days (B). C: The graph illustrates the AL gene induction in NH4Cl treated aggregates (mean ± 
SD, n=3). The very low expression of AS did not allow any reliable densitometric 
quantification. 
 
Fig. 2: Cell type specific expression of AS and AL mRNAs in day 13 aggregates. In situ 
hybridization with antisense probes for AS (A,C) and AL (B,D) and sense probes for AS (J) 
and AL (L). Immunohistochemistry for MAP2 (E,G) and GFAP (F,H). May-Grünwald 
coloration (I,K). Aggregates treated from day 5 to 13 with 5 mM NaCl (controls, A,B,E,F,I,J) 
or 5 mM NH4Cl (C,D,G,H,K,L). Neurons are indicated by arrowheads, astrocytes by arrows, 
and the dense peripheral fiber zone by asterisks. Pictures J and L (sense control probes) taken 
in Nomarski optic. Bar: 100 µm. 
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